A round-up of the year that was 2020, from Mercia’s commercial perspective and including presentations from the Fund Principals and the fund and various portfolio companies. This event is hosted by Paul Mattick, and includes presentations from Dr Mark Payton (CEO) on the Mercia Asset Management interim results, Peter Dines (COO) on the EIS and
With change comes challenge, but change also brings opportunity. There has been no time to really take a step back to plan well for Brexit. COVID-19 made it difficult for many businesses to do anything more than firefight. But it’s never too late and we are offering you, through this webinar, the time and the
As the UK readies itself to leave the EU on January 1st 2021, what will be the state of the UK’s economy post-Brexit? The economy has already taken a huge hit because of the COVID pandemic, so where do we go from here and what does it look like? Join renowned economist, John Ashcroft as
‘The Brexit Series’ continues with this insight into Foreign Exchange and its future impact because of Brexit. Join Joseph Stevens and James Dazeley of Global Reach Group, where they will be casting light on numerous topics including the current FX markets and the key drivers that will affect FX markets in a post-Brexit world. Register
We were joined by experts Nick Wildgoose, Nigel Miers, Andy Collier and Haider Mawji in this discussion, where the panel outlined what lies ahead for the future of the Financial Director and Chief Financial Officer role in 2021 and beyond. The panel share decades of experience, whilst covering key topics such as managing costs, cashflow
Investment Director Jill Williams explains how Mercia’s core values have accelerated the Group’s environmental, social and governance (“ESG”) journey and how best practice is vital in moving forward. Our mantra at Mercia is ‘in the regions, from the regions, to the regions’. We passionately believe in making a positive and sustainable regional impact. This is
The top 50 tech businesses in the Midlands from start up to established players included eight within Mercia’s portfolio: Adapttech Birmingham-based Adapttech was founded in 2015 by biomedical engineers Frederico Carpinteiro and Mario Saenz Espinoza. Its INSIGHT tool offers a faster and easier way to fit lower-limb prostheses and monitor patients’ rehabilitation. Staff Circle Leicestershire-based
Over the last six months Mercia has seen investment levels similar to those of the same period last year. Increased levels of co-investment have in part been driven by the introduction of the Future Fund initiative but certainly, capital deployment from Mercia has not slowed down as a result of COVID-19. Mercia’s CIO, Julian Viggars,
Ryan Cawood, CEO and Jocelyne Bath, COO – OXGENE recently outlined OXGENE’s beginnings, how Mercia’s latest investment has helped their biotechnology business successfully scale and their plans post COVID-19. The Life Sciences portfolio collectively accounts for approximately 30% of the portfolio and this interview with Edison’s outlines: Why Mercia invests in the sector
Since 2015 the Northern VCTs have achieved 26 exits from the mature portfolio generating proceeds of £183.2 million and an average return multiple of 2.7x (as at September 2019). It’s a track record which speaks for itself. Today, as part of the Mercia Group (having been acquired from NVM Private Equity in 2019), the